XBIOTECH INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- XBIOTECH INC. stock issued during period, value, new issues for the quarter ending 2019-12-31 was $575.00K.
- XBIOTECH INC. stock issued during period, value, new issues for the quarter ending 2019-09-30 was -$10.00K.
- XBIOTECH INC. stock issued during period, value, new issues for the quarter ending 2019-06-30 was $37.50M.
- XBIOTECH INC. stock issued during period, value, new issues for fiscal 2019 was $38.06M.
- XBIOTECH INC. stock issued during period, value, new issues for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- XBIOTECH INC. stock issued during period, value, new issues for fiscal 2017 was $32.62M, a 1704.20% increase from fiscal 2016.
- XBIOTECH INC. stock issued during period, value, new issues for fiscal 2016 was $1.81M, a 97.60% decline from fiscal 2015.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2019-12-31 | $575.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $38.06M 10-K · filed 2022-03-15 |
| 2019-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | |
| 2019-06-30 | $37.50M 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $0.00 10-K · filed 2021-03-16 | |
| 2017-12-31 | $32.62M 10-K · filed 2020-03-16 | |
| 2016-12-31 | $1.81M 10-K/A · filed 2019-03-15 | |
| 2015-12-31 | $75.39M 10-K · filed 2018-03-16 | |
| 2014-12-31 | $63.78M 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |